ADI Commitment on Vaccine development and production

Promote and invest in regional capacity for the development and production of vaccines in line with the African Union Pharmaceutical Manufacturing Plan including the strengthening of national regulatory authorities.

Why it matters

Africa has the highest incidence of mortality caused by infectious diseases, yet has limited capacity to manufacture affordable, essential vaccines. Additional efforts are needed in this area to enhance regulatory oversight for the development and approval of new vaccines that meet quality, safety, and efficacy standards and build manufacturing capacity.